Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06314295

Automated Echocardiographic Detection of Coronary Artery Disease Using Artificial Intelligence Methods

The incidence rate and mortality of coronary artery disease are increasing year by year. Exploring non-invasive, accurate, and widely applicable methods to screen and diagnosis is of great significance. New ultrasound techniques, such as non-invasive myocardial work, have been proven to be superior to traditional ultrasound techniques in screening and diagnosis. However, diagnostic analysis based on ultrasound video images is time-consuming and subjective. The progress of artificial intelligence technology in fully automated quantitative evaluation of video images provides the possibility for computer-aided design screening and diagnosis. At present, the application of artificial intelligence in computer-aided design is a cutting-edge issue in the field of cardiovascular disease research. The application of artificial intelligence technology in the construction of computer-aided diagnostic models based on ultrasound video images is still in its early stages.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing Hospital

Beijing, China

Location status: Recruiting

Location contact

Fang Wang, Dr

CONTACT

[email protected]

About this study

  • Clarify the value of new cardiac ultrasound techniques indicators in coronary artery disease diagnosis; 2) To achieve classification and detection of cardiac ultrasound sections; Implementing automatic segmentation and recognition of the left ventricular cavity, left ventricular myocardium, and left atrial wall contours through the CLAS model; Using the another model to achieve heart motion tracking and synthesizing velocity vector maps of the heart flow field. 3) Verify and optimize the coronary artery disease fully automated artificial intelligence diagnostic model mentioned above.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with suspected coronary artery disease
  • Patients plan to undergo coronary angiography

Exclusion criteria

  • Patients with aortic valve stenosis
  • Patients with aortic valve replacement surgery
  • Patients with hypertrophic cardiomyopathy
  • Patients with severe heart valve disease
  • Patients with severe arrhythmia
  • Patients with severe cardiomyopathy
  • Patients with severe congenital heart disease
  • The quality of ultrasound images is poor

Treatment and study plan

Primary outcomes

  1. Different coronary angiography results

    Time frame: Coronary angiography examination within 2-3 days after admission

    The degree of coronary artery stenosis

Sponsors and collaborators

Lead sponsor

Beijing Hospital

Other Gov

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Mar 18, 2024
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.